Tyra Biosciences Inc’s filing revealed that its Director KAPLAN GILLA unloaded Company’s shares for reported $93596.0 on Jun 18 ’25. In the deal valued at $9.78 per share,9,568 shares were sold. As a result of this transaction, KAPLAN GILLA now holds 28,231 shares worth roughly $0.32 million.
Then, KAPLAN GILLA sold 10 shares, generating $104 in total proceeds. Upon selling the shares at $10.35, the Director now owns 37,799 shares.
Before that, GILLA KAPLAN bought 9,568 shares. Tyra Biosciences Inc shares valued at $93,596 were divested by the Director at a price of $9.78 per share.
A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. BofA Securities also remained covering TYRA and has increased its forecast on October 18, 2024 with a “Buy” recommendation from previously “Neutral” rating. Piper Sandler started covering the stock on August 15, 2024. It rated TYRA as “an Overweight”.
Price Performance Review of TYRA
On Tuesday, Tyra Biosciences Inc [NASDAQ:TYRA] saw its stock jump 7.51% to $11.45. Over the last five days, the stock has gained 2.23%. Tyra Biosciences Inc shares have fallen nearly -46.77% since the year began. Nevertheless, the stocks have fallen -17.63% over the past one year.
How much short interest is there in Tyra Biosciences Inc?
A steep rise in short interest was recorded in Tyra Biosciences Inc stocks on 2025-07-15, growing by 0.78 million shares to a total of 6.04 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 5.26 million shares. There was a rise of 12.88%, which implies that there is a positive sentiment for the stock.
